Apalutamide is a nonsteroidal androgen receptor inhibitor indicated for the treatment of non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. By binding… Read more



![Chemical structure of Methyl 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1950587-19-5-Methyl-4-7-6-cyano-5-trifluoromethylpyridin-3-yl-8-oxo-6-thioxo-57-diazaspiro3.4octan-5-yl-2-fluorobenzoate.png&w=3840&q=75)









![Chemical structure of O-Phenyl (4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoyl)(methyl)carbamothioate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2894796-78-0-O-Phenyl-4-7-6-cyano-5-trifluoromethylpyridin-3-yl-8-oxo-6-thioxo-57-diazaspiro3.4octan-5-yl-2-fluorobenzoylmethylcarbamothioate.png&w=3840&q=75)
![Chemical structure of O-Phenyl (4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoyl)(methyl)carbamothioate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FO-Phenyl-4-7-6-cyano-5-trifluoromethylpyridin-3-yl-8-oxo-6-thioxo-57-diazaspiro3.4octan-5-yl-2-fluorobenzoylmethylcarbamothioate.png&w=3840&q=75)
![Chemical structure of Sodium 4-(7-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluorobenzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-4-7-6-cyano-5-trifluoromethylpyridin-3-yl-8-oxo-6-thioxo-57-diazaspiro3.4octan-5-yl-2-fluorobenzoate.png&w=3840&q=75)

Apalutamide is a nonsteroidal androgen receptor inhibitor indicated for the treatment of non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. By binding directly to the androgen receptor ligand-binding domain, it blocks androgen binding, preventing nuclear translocation and subsequent gene transcription that drives tumor cell growth. This category includes high-quality pharmaceutical reference standards essential for analytical testing, quality control, and regulatory compliance. These products comprise synthetic intermediates, process-related impurities, degradation products, and stable isotope-labelled compounds required by laboratories for impurity profiling, stability studies, and method validation. By utilizing these characterized materials as comparison benchmarks, researchers can accurately identify and quantify impurities, ensure drug purity, and maintain data integrity throughout the drug development lifecycle in accordance with established guidelines.